• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美法仑热灌注隔离治疗下肢晚期恶性黑色素瘤

Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb.

作者信息

Skene A I, Bulman A S, Williams T R, Thomas J M, Westbury G

机构信息

Department of Academic Surgery, Royal Marsden Hospital, London, UK.

出版信息

Br J Surg. 1990 Jul;77(7):765-7. doi: 10.1002/bjs.1800770716.

DOI:10.1002/bjs.1800770716
PMID:2383752
Abstract

A retrospective study of 91 patients with malignant melanoma treated by lower limb isolated hyperthermic regional perfusion was performed. Objective response in patients with evaluable disease was 78 per cent. The role of perfusion as primary treatment of large melanomas of the foot is confirmed and recommended. Control of locoregional disease and limb salvage remains a valuable and attainable therapeutic goal using this technique.

摘要

对91例接受下肢孤立性热灌注治疗的恶性黑色素瘤患者进行了回顾性研究。可评估疾病患者的客观缓解率为78%。证实并推荐灌注作为足部大型黑色素瘤的主要治疗方法。使用该技术控制局部区域疾病和保肢仍然是一个有价值且可实现的治疗目标。

相似文献

1
Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb.美法仑热灌注隔离治疗下肢晚期恶性黑色素瘤
Br J Surg. 1990 Jul;77(7):765-7. doi: 10.1002/bjs.1800770716.
2
[Regional chemotherapy--perfusion of the extremities].[区域化疗——肢体灌注]
Kongressbd Dtsch Ges Chir Kongr. 2001;118:200-4.
3
Isolation perfusion for malignant melanoma of the extremity: a review.肢体恶性黑色素瘤的隔离灌注:综述
J Clin Oncol. 1985 Jul;3(7):1022-31. doi: 10.1200/JCO.1985.3.7.1022.
4
Prophylactic hyperthermic limb perfusion in stage I melanoma.I期黑色素瘤的预防性肢体热灌注
Eur J Surg Oncol. 1988 Aug;14(4):321-6.
5
Modification of human tumour and normal tissue pH during hyperthermic and normothermic antiblastic regional isolation perfusion for malignant melanoma: a pilot study.恶性黑色素瘤热疗和常温抗瘤区域隔离灌注期间人体肿瘤及正常组织pH值的变化:一项初步研究
Int J Hyperthermia. 1993 Mar-Apr;9(2):205-17. doi: 10.3109/02656739309022535.
6
[Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].[肿瘤坏死因子α与基于美法仑的高温隔离肢体灌注治疗局部晚期肢体软组织肉瘤和黑色素瘤]
Cir Esp. 2012 Feb;90(2):114-20. doi: 10.1016/j.ciresp.2011.10.012. Epub 2012 Jan 5.
7
Four times repeated isolated limb infusion with melphalan-controlled locoregional disease in the patient with melanoma of the leg.对腿部黑色素瘤患者进行了4次美法仑重复孤立肢体灌注,控制了局部区域疾病。
Am Surg. 2012 Dec;78(12):E504-5.
8
[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].[美法仑和肿瘤坏死因子在恶性黑色素瘤中的肢体隔离热灌注治疗]
Dtsch Med Wochenschr. 1997 Feb 14;122(7):177-81. doi: 10.1055/s-2008-1047593.
9
Isolated hyperthermic perfusion with mitoxantrone of melphalan in malignant melanoma of the limb.
Am J Surg. 1995 Oct;170(4):345-52. doi: 10.1016/s0002-9610(99)80301-8.
10
Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US.
Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1033-7. doi: 10.1517/17425250903559881.

引用本文的文献

1
Predicting disease progression after regional therapy for in-transit melanoma.预测转移性黑色素瘤区域治疗后的疾病进展。
JAMA Surg. 2013 Jun;148(6):493-8. doi: 10.1001/jamasurg.2013.695.
2
A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity.一项多机构 I 期研究,评估索拉非尼联合区域性美法仑治疗肢体转移性黑色素瘤。
Ann Surg Oncol. 2012 Nov;19(12):3896-3905. doi: 10.1245/s10434-012-2373-8. Epub 2012 May 2.
3
Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.
当前黑色素瘤区域性治疗的趋势:单个机构 1995 年至 2010 年间 225 例区域性化疗治疗的经验教训。
J Am Coll Surg. 2011 Aug;213(2):306-16. doi: 10.1016/j.jamcollsurg.2011.03.013. Epub 2011 Apr 13.
4
Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.前瞻性多中心 II 期临床试验:全身性 ADH-1 联合马法兰经肢体隔离灌注治疗晚期肢体黑色素瘤。
J Clin Oncol. 2011 Mar 20;29(9):1210-5. doi: 10.1200/JCO.2010.32.1224. Epub 2011 Feb 22.
5
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.一项关于全身性ADH - 1联合美法仑通过隔离肢体灌注用于局部晚期转移性恶性黑色素瘤患者的1期研究。
Cancer. 2009 Oct 15;115(20):4766-74. doi: 10.1002/cncr.24509.
6
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?优化美法仑在局部黑色素瘤治疗中的药代动力学:校正理想体重是否会改变局部反应或毒性?
Ann Surg Oncol. 2009 Apr;16(4):953-61. doi: 10.1245/s10434-008-0288-1. Epub 2009 Jan 30.
7
Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: the experience of the Tuscan Reference Centre.托斯卡纳参考中心242例皮肤黑色素瘤化疗热灌注治疗中孤立性下肢灌注后的毒性和发病率
J Exp Clin Cancer Res. 2008 Nov 12;27(1):67. doi: 10.1186/1756-9966-27-67.
8
Exercising in environmental extremes : a greater threat to immune function?在极端环境中锻炼:对免疫功能构成更大威胁?
Sports Med. 2006;36(11):941-76. doi: 10.2165/00007256-200636110-00003.
9
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.肢体软组织肉瘤、途中转移瘤及其他不可切除肿瘤的隔离肢体灌注:优点、缺点及未来展望
Curr Oncol Rep. 2001 Jul;3(4):359-67. doi: 10.1007/s11912-001-0090-8.
10
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanoma.体外循环中采用白细胞介素-2和淋巴因子激活的杀伤细胞进行隔离灌注治疗肢体皮肤黑色素瘤的移行转移灶
Ann Surg Oncol. 1995 Jan;2(1):61-70. doi: 10.1007/BF02303704.